vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and ESCO TECHNOLOGIES INC (ESE). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $289.7M, roughly 1.2× ESCO TECHNOLOGIES INC). ESCO TECHNOLOGIES INC runs the higher net margin — 9.9% vs -0.8%, a 10.7% gap on every dollar of revenue. On growth, ESCO TECHNOLOGIES INC posted the faster year-over-year revenue change (17.3% vs 9.4%). ESCO TECHNOLOGIES INC produced more free cash flow last quarter ($63.0M vs $36.1M). Over the past eight quarters, ESCO TECHNOLOGIES INC's revenue compounded faster (7.8% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Esco is a Singaporean brand that develops, manufactures, and sells products and services for laboratories.
ASIX vs ESE — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $289.7M |
| Net Profit | $-2.8M | $28.7M |
| Gross Margin | 7.6% | 41.4% |
| Operating Margin | -0.7% | 13.2% |
| Net Margin | -0.8% | 9.9% |
| Revenue YoY | 9.4% | 17.3% |
| Net Profit YoY | -892.9% | 22.2% |
| EPS (diluted) | $-0.11 | $1.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $289.7M | ||
| Q3 25 | $374.5M | $286.5M | ||
| Q2 25 | $410.0M | $296.3M | ||
| Q1 25 | $377.8M | $265.5M | ||
| Q4 24 | $329.1M | $247.0M | ||
| Q3 24 | $398.2M | $298.5M | ||
| Q2 24 | $453.5M | $260.8M | ||
| Q1 24 | $336.8M | $249.1M |
| Q4 25 | $-2.8M | $28.7M | ||
| Q3 25 | $-2.6M | $218.7M | ||
| Q2 25 | $31.4M | $26.1M | ||
| Q1 25 | $23.3M | $31.0M | ||
| Q4 24 | $352.0K | $23.5M | ||
| Q3 24 | $22.3M | $34.3M | ||
| Q2 24 | $38.9M | $29.2M | ||
| Q1 24 | $-17.4M | $23.2M |
| Q4 25 | 7.6% | 41.4% | ||
| Q3 25 | 6.8% | 45.9% | ||
| Q2 25 | 14.3% | 41.2% | ||
| Q1 25 | 14.2% | 41.1% | ||
| Q4 24 | 3.4% | 39.8% | ||
| Q3 24 | 14.4% | 40.1% | ||
| Q2 24 | 17.9% | 39.6% | ||
| Q1 24 | 0.9% | 38.8% |
| Q4 25 | -0.7% | 13.2% | ||
| Q3 25 | -0.9% | 17.2% | ||
| Q2 25 | 7.7% | 11.2% | ||
| Q1 25 | 7.7% | 15.3% | ||
| Q4 24 | -3.9% | 11.4% | ||
| Q3 24 | 7.5% | 14.8% | ||
| Q2 24 | 11.5% | 14.3% | ||
| Q1 24 | -7.0% | 11.7% |
| Q4 25 | -0.8% | 9.9% | ||
| Q3 25 | -0.7% | 76.3% | ||
| Q2 25 | 7.7% | 8.8% | ||
| Q1 25 | 6.2% | 11.7% | ||
| Q4 24 | 0.1% | 9.5% | ||
| Q3 24 | 5.6% | 11.5% | ||
| Q2 24 | 8.6% | 11.2% | ||
| Q1 24 | -5.2% | 9.3% |
| Q4 25 | $-0.11 | $1.11 | ||
| Q3 25 | $-0.10 | $8.43 | ||
| Q2 25 | $1.15 | $1.01 | ||
| Q1 25 | $0.86 | $1.20 | ||
| Q4 24 | $0.02 | $0.91 | ||
| Q3 24 | $0.82 | $1.32 | ||
| Q2 24 | $1.43 | $1.13 | ||
| Q1 24 | $-0.65 | $0.90 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $103.8M |
| Total DebtLower is stronger | — | $145.5M |
| Stockholders' EquityBook value | $815.2M | $1.6B |
| Total Assets | $1.7B | $2.4B |
| Debt / EquityLower = less leverage | — | 0.09× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $103.8M | ||
| Q3 25 | $23.7M | $101.3M | ||
| Q2 25 | $18.4M | $78.7M | ||
| Q1 25 | $8.3M | $57.4M | ||
| Q4 24 | $19.6M | $71.3M | ||
| Q3 24 | $17.3M | $66.0M | ||
| Q2 24 | $12.1M | $63.0M | ||
| Q1 24 | $20.6M | $59.4M |
| Q4 25 | — | $145.5M | ||
| Q3 25 | — | $186.0M | ||
| Q2 25 | — | $525.0M | ||
| Q1 25 | — | $88.0M | ||
| Q4 24 | — | $112.0M | ||
| Q3 24 | — | $122.0M | ||
| Q2 24 | — | $173.0M | ||
| Q1 24 | — | $191.0M |
| Q4 25 | $815.2M | $1.6B | ||
| Q3 25 | $818.2M | $1.5B | ||
| Q2 25 | $823.7M | $1.3B | ||
| Q1 25 | $794.4M | $1.3B | ||
| Q4 24 | $774.6M | $1.2B | ||
| Q3 24 | $766.4M | $1.2B | ||
| Q2 24 | $746.6M | $1.2B | ||
| Q1 24 | $713.2M | $1.2B |
| Q4 25 | $1.7B | $2.4B | ||
| Q3 25 | $1.7B | $2.4B | ||
| Q2 25 | $1.6B | $2.5B | ||
| Q1 25 | $1.6B | $1.8B | ||
| Q4 24 | $1.6B | $1.8B | ||
| Q3 24 | $1.5B | $1.8B | ||
| Q2 24 | $1.5B | $1.8B | ||
| Q1 24 | $1.5B | $1.8B |
| Q4 25 | — | 0.09× | ||
| Q3 25 | — | 0.12× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.07× | ||
| Q4 24 | — | 0.09× | ||
| Q3 24 | — | 0.10× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $68.9M |
| Free Cash FlowOCF − Capex | $36.1M | $63.0M |
| FCF MarginFCF / Revenue | 10.0% | 21.7% |
| Capex IntensityCapex / Revenue | 7.7% | 2.0% |
| Cash ConversionOCF / Net Profit | — | 2.40× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $239.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $68.9M | ||
| Q3 25 | $26.6M | $109.9M | ||
| Q2 25 | $21.1M | $73.7M | ||
| Q1 25 | $11.4M | $24.1M | ||
| Q4 24 | $64.2M | $34.2M | ||
| Q3 24 | $57.3M | $72.1M | ||
| Q2 24 | $50.2M | $36.2M | ||
| Q1 24 | $-36.2M | $10.5M |
| Q4 25 | $36.1M | $63.0M | ||
| Q3 25 | $66.0K | $97.8M | ||
| Q2 25 | $-7.2M | $64.9M | ||
| Q1 25 | $-22.6M | $14.0M | ||
| Q4 24 | $29.8M | $29.0M | ||
| Q3 24 | $26.8M | $60.9M | ||
| Q2 24 | $16.7M | $27.6M | ||
| Q1 24 | $-71.6M | $2.0M |
| Q4 25 | 10.0% | 21.7% | ||
| Q3 25 | 0.0% | 34.1% | ||
| Q2 25 | -1.7% | 21.9% | ||
| Q1 25 | -6.0% | 5.3% | ||
| Q4 24 | 9.1% | 11.7% | ||
| Q3 24 | 6.7% | 20.4% | ||
| Q2 24 | 3.7% | 10.6% | ||
| Q1 24 | -21.3% | 0.8% |
| Q4 25 | 7.7% | 2.0% | ||
| Q3 25 | 7.1% | 4.2% | ||
| Q2 25 | 6.9% | 3.0% | ||
| Q1 25 | 9.0% | 3.8% | ||
| Q4 24 | 10.4% | 2.1% | ||
| Q3 24 | 7.7% | 3.8% | ||
| Q2 24 | 7.4% | 3.3% | ||
| Q1 24 | 10.5% | 3.4% |
| Q4 25 | — | 2.40× | ||
| Q3 25 | — | 0.50× | ||
| Q2 25 | 0.67× | 2.83× | ||
| Q1 25 | 0.49× | 0.78× | ||
| Q4 24 | 182.29× | 1.46× | ||
| Q3 24 | 2.57× | 2.10× | ||
| Q2 24 | 1.29× | 1.24× | ||
| Q1 24 | — | 0.45× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
ESE
| US Government | $98.0M | 34% |
| Utility Solutions Group | $87.5M | 30% |
| RF Shielding And Test | $58.3M | 20% |
| Commercial | $45.8M | 16% |
| Related Party | $1.3M | 0% |
